KC
MNTA

Kellner Capital’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Kellner Capital’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-260,300
Closed -$13.7M – 47
2020
Q3 		$13.7M Buy
+260,300
New +$10.8M 7.39% 5

Kellner Capital's MNTA Position: Q4 2020 in Review

Kellner Capital sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 260,300 shares — an estimated $13.7M sold.

Kellner Capital first reported a position in MNTA in Q3 2020 and held it in 1 quarter. The position peaked at $13.7M in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

  • Kellner Capital reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Kellner Capital sold 260,300 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $13.7M.
  • Kellner Capital first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2020 and held it in 1 quarter.
  • Kellner Capital's Momenta Pharmaceuticals, Inc. position peaked at $13.7M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Kellner Capital's 13F filing for Q4 2020, filed 10 Feb 2021.